Document Detail


Advances in predicting acute GVHD.
MedLine Citation:
PMID:  23205489     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute graft-versus-host disease (GVHD) is a leading cause of non-relapse mortality following allogeneic haematopoietic cell transplantation. Attempts to improve treatment response in clinically-established GVHD have not improved overall survival, often due to the increased risk of infectious complications. Alternative approaches to decrease GVHD-related morbidity and mortality have focused on the ability to predict GVHD prior to clinical manifestation in an effort to provide an opportunity to abort GVHD development, and to gain new insights into GVHD pathophysiology. This review outlines the research efforts to date that have identified clinical and laboratory-based factors that are predictive of acute GVHD and describes future directions in developing algorithms that will improve the ability to predict the development of clinically relevant GVHD.
Authors:
Andrew C Harris; James L M Ferrara; John E Levine
Related Documents :
18034629 - Development and manufacture of an investigational human living dermal equivalent (icx-s...
23916549 - Three-dimensional renal ct angiography for guiding segmental renal artery clamping duri...
23963539 - A case of renal γ2 heavy-chain deposition disease accompanied by rapid progressive ren...
24910299 - Kidney allograft function and histology in recipients dying with a functioning graft.
11368539 - Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts pl...
22992939 - Testicular tissue grafting and male germ cell transplantation.
3353589 - Nodular renal blastema and metanephric hamartomas in children with urinary tract malfor...
22260219 - Different outcomes of atherosclerotic renal artery stenosis managed with stenting: resu...
12673249 - Cannibalism in the madagascan dinosaur majungatholus atopus.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2012-12-04
Journal Detail:
Title:  British journal of haematology     Volume:  160     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-21     Completed Date:  2013-06-14     Revised Date:  2014-02-04    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  288-302     Citation Subset:  IM    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Biological Markers / blood
Graft vs Host Disease / diagnosis*,  etiology*
Hematopoietic Stem Cell Transplantation / adverse effects
Humans
Prognosis
Risk Factors
Transplantation Conditioning
Transplantation, Homologous
Transplants
Grant Support
ID/Acronym/Agency:
P01 CA039542/CA/NCI NIH HHS; P01-CA039542/CA/NCI NIH HHS; U10 HL069330/HL/NHLBI NIH HHS; U10-HL069330/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Higher allergenicity of high molecular weight hydrolysed wheat protein in cosmetics for percutaneous...
Next Document:  Pittsburgh and Epworth Sleep Scale Items: Accuracy of Ratings Across Different Reporting Periods.